{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388844982885376.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1172/jci117269"}},{"identifier":{"@type":"URI","@value":"http://www.jci.org/articles/view/117269/files/pdf"}}],"dc:title":[{"@value":"Mineralocorticoids, hypertension, and cardiac fibrosis."}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004231299896705","@type":"Researcher","foaf:name":[{"@value":"M Young"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844982885378","@type":"Researcher","foaf:name":[{"@value":"M Fullerton"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844982885379","@type":"Researcher","foaf:name":[{"@value":"R Dilley"}]},{"@id":"https://cir.nii.ac.jp/crid/1383388844982885377","@type":"Researcher","foaf:name":[{"@value":"J Funder"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00219738"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00219738"},{"@type":"PISSN","@value":"https://id.crossref.org/issn/00219738"}],"prism:publicationName":[{"@value":"Journal of Clinical Investigation"}],"dc:publisher":[{"@value":"American Society for Clinical Investigation"}],"prism:publicationDate":"1994-06-01","prism:volume":"93","prism:number":"6","prism:startingPage":"2578","prism:endingPage":"2583"},"reviewed":"false","url":[{"@id":"http://www.jci.org/articles/view/117269/files/pdf"}],"createdAt":"2008-02-29","modifiedAt":"2023-08-03","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360846640991454080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Salt accelerates aldosterone-induced cardiac remodeling in the absence of guanylyl cyclase-A signaling"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643661324800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mineralocorticoid Receptors, Salt-Sensitive Hypertension, and Metabolic Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204720126720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Influence of Plasma Aldosterone on Left Ventricular Geometry and Diastolic Function in Treated Essential Hypertension."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205104947968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Left Ventricular Hypertrophy and Geometry in Untreated Essential Hypertension is Associated With Blood Levels of Aldosterone and Procollagen Type III Amino-Terminal Peptide"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679697516416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Aldosterone-Induced Organ Damage: Plasma Aldosterone Level and Inappropriate Salt Status"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681421205376","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"5) Renal Failure and Aldosterone"},{"@language":"ja","@value":"5）腎疾患とアルドステロン"},{"@value":"腎疾患とアルドステロン"},{"@language":"ja-Kana","@value":"ジンシッカン ト アルドステロン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564227306263808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure　― Digest Version ―"},{"@value":"JCS GUIDELINES : JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure : Digest Version"},{"@value":"Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure- Digest Version"},{"@value":"JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure—Digest Version"},{"@value":"JCS 2017/JHFS 2017 Guideline on diagnosis and treatment of acute and chronic heart failure — digest version —"},{"@value":"JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure"},{"@value":"JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure- digest version. JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure- digest version"},{"@value":"Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure—Digest Version"},{"@value":"Japanese Circulation Society and the Japanese Heart Failure Society Joint Working Group. Guidelines for diagnosis and treatment of acute and chronic heart failure"}]},{"@id":"https://cir.nii.ac.jp/crid/2051996266980601600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1172/jci117269"},{"@type":"CROSSREF","@value":"10.1007/s10157-010-0298-8_references_DOI_Aa55kpamYw8XU1pnZCRjHoFR1Rz"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-19-0342_references_DOI_Aa55kpamYw8XU1pnZCRjHoFR1Rz"},{"@type":"CROSSREF","@value":"10.1016/j.lfs.2016.09.011_references_DOI_Aa55kpamYw8XU1pnZCRjHoFR1Rz"},{"@type":"CROSSREF","@value":"10.2169/naika.97.2171_references_DOI_Aa55kpamYw8XU1pnZCRjHoFR1Rz"},{"@type":"CROSSREF","@value":"10.1253/circj.71.716_references_DOI_Aa55kpamYw8XU1pnZCRjHoFR1Rz"},{"@type":"CROSSREF","@value":"10.1291/hypres.25.49_references_DOI_Aa55kpamYw8XU1pnZCRjHoFR1Rz"},{"@type":"CROSSREF","@value":"10.1161/hypertensionaha.109.149062_references_DOI_Aa55kpamYw8XU1pnZCRjHoFR1Rz"},{"@type":"CROSSREF","@value":"10.1291/hypres.27.303_references_DOI_Aa55kpamYw8XU1pnZCRjHoFR1Rz"}]}